<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Musculoskelet Disord</journal-id><journal-id journal-id-type="pmc-domain-id">46</journal-id><journal-id journal-id-type="pmc-domain">bmcmudis</journal-id><journal-title-group><journal-title>BMC Musculoskeletal Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10394767</article-id><article-id pub-id-type="pmcid-ver">PMC10394767.1</article-id><article-id pub-id-type="pmcaid">10394767</article-id><article-id pub-id-type="pmcaiid">10394767</article-id><article-id pub-id-type="pmid">37532980</article-id><article-id pub-id-type="doi">10.1186/s12891-023-06764-5</article-id><article-id pub-id-type="publisher-id">6764</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Incidence and risk factors of isolated calf muscular venous thrombosis after tibial plateau fractures surgery</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Peng</surname><given-names initials="J">Jian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Feng</surname><given-names initials="B">Bin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Ren</surname><given-names initials="W">Weizhi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="S">Shijie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="C">Chenying</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hu</surname><given-names initials="Z">Zhenghui</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Xu</surname><given-names initials="W">Wei</given-names></name><address><email>13962157016@139.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.452666.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1762 8363</institution-id><institution>Department of Orthopedics, </institution><institution>The Second Affiliated Hospital of Soochow University, </institution></institution-wrap>No.1055, SanXiang Road, Gusu District, Suzhou, Jiangsu Province 215004 PR China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.452666.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1762 8363</institution-id><institution>Department of Radiology, </institution><institution>The Second Affiliated Hospital of Soochow University, </institution></institution-wrap>No.1055, SanXiang Road, Gusu District, Suzhou, 215004 China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>24</volume><issue-id pub-id-type="pmc-issue-id">424962</issue-id><elocation-id>625</elocation-id><history><date date-type="received"><day>17</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>03</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-04 08:25:14.350"><day>04</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12891_2023_Article_6764.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The risks associated with deep vein thrombosis (DVT) have gained significant recognition over time. A prevalent form of distal DVT is isolated calf muscular venous thrombosis (ICMVT). Despite its common clinical occurrence, data on ICMVT subsequent to tibial plateau fracture (TPF) surgery are scarce. This study aimed to examine the epidemiological characteristics and associated risk factors (RFs) of ICMVT following TPF surgery.</p></sec><sec><title>Methods</title><p id="Par2">For this retrospective analysis, we included patients from our hospital, who underwent TPF surgery between March 2017 and March 2021. Patients&#8217; electronic medical records were reviewed, including admission details, fracture classification, surgical procedures, and laboratory biomarkers. The HSS (The American Hospital for Special Surgery) and Rasmussen scores were employed to evaluate the clinical effect. A Color Duplex Flow Imager (CDFI) was regularly used to detect pre- and postoperative venous thrombosis in the lower limbs. Finally, uni- and multivariate logistic regression analyses were used to identify independent RFs associated with ICMVT.</p></sec><sec><title>Results</title><p id="Par3">Overall, 481 participants were recruited for analysis. Postoperative ICMVT occurred in 47 patients. All ICMVTs occurred on the affected side. Four of the 47 ICMVT patients exhibited sudden postoperative swelling in the affected limb. The HSS and Rasmussen scores in the non-ICMVT cohort (87.6&#8201;&#177;&#8201;8.2, 16.0&#8201;&#177;&#8201;1.7) were markedly different from the ICMVT cohort (84.8&#8201;&#177;&#8201;8.2, 15.5&#8201;&#177;&#8201;1.6) (<italic toggle="yes">p</italic>&#8201;=&#8201;0.014, <italic toggle="yes">p</italic>&#8201;=&#8201;0.031). This study finally identified five postoperative ICMVT-related RFs, which were age (&gt;&#8201;55&#160;years old) (OR 3.06; 95% CI 1.47&#8211;6.37; <italic toggle="yes">p</italic>&#8201;=&#8201;0.003), gender (female) (OR 2.67; 95% CI 1.37&#8211;5.22; <italic toggle="yes">p</italic>&#8201;=&#8201;0.004), surgical duration (&gt;&#8201;114&#160;min) (OR 3.14; 95% CI 1.44&#8211;6.85; <italic toggle="yes">p</italic>&#8201;=&#8201;0.004), elevated white blood cell content (OR 2.85; 95% CI 1.47&#8211;5.51; <italic toggle="yes">p</italic>&#8201;=&#8201;0.002), and hyponatremia (OR 2.31; 95% CI 1.04&#8211;5.12; <italic toggle="yes">p</italic>&#8201;=&#8201;0.040).</p></sec><sec><title>Conclusion</title><p id="Par4">The epidemiological findings of this study may help predict ICMVT risk after surgery thus facilitating the development of individualized clinical assessments and targeted prevention programs.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Tibial plateau fractures</kwd><kwd>Isolated calf muscular venous thrombosis</kwd><kwd>Incidence</kwd><kwd>Risk factors</kwd></kwd-group><funding-group><award-group><funding-source><institution>Natural Science Fund of China</institution></funding-source><award-id>81874008</award-id><award-id>81874008</award-id><award-id>81874008</award-id><award-id>81874008</award-id><award-id>81874008</award-id><award-id>81874008</award-id><award-id>81874008</award-id><principal-award-recipient><name name-style="western"><surname>Peng</surname><given-names>Jian</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Bin</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Weizhi</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Shijie</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Chenying</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Zhenghui</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Soochow Health Program of talent training</institution></funding-source><award-id>GSWS2019010</award-id><award-id>GSWS2019010</award-id><award-id>GSWS2019010</award-id><award-id>GSWS2019010</award-id><award-id>GSWS2019010</award-id><award-id>GSWS2019010</award-id><award-id>GSWS2019010</award-id><principal-award-recipient><name name-style="western"><surname>Peng</surname><given-names>Jian</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Bin</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Weizhi</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Shijie</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Chenying</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Zhenghui</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Suzhou key Disciplines</institution></funding-source><award-id>SZXK202104</award-id><award-id>SZXK202104</award-id><award-id>SZXK202104</award-id><award-id>SZXK202104</award-id><award-id>SZXK202104</award-id><award-id>SZXK202104</award-id><award-id>SZXK202104</award-id><principal-award-recipient><name name-style="western"><surname>Peng</surname><given-names>Jian</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Bin</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Weizhi</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Shijie</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Chenying</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Zhenghui</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par18">Tibial plateau fracture (TPF) is very common in clinical practice [<xref ref-type="bibr" rid="CR1">1</xref>]. Currently, the main treatment for obvious displacement TPF is surgery. TPFs induce a series of changes, including extremity swelling and limited mobility, leading to slow blood flow, trauma and inflammatory responses contribute to hypercoagulation, and trauma and surgical procedures can damage the vascular endothelium [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. These factors increase the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), a severe and potentially fatal complication that can occur after major orthopedic surgery. According to the location of the thrombus, DVT can be divided into proximal DVT and distal DVT. It is generally believed that proximal DVT mainly causes the occurrence of PE. However, distal DVT can also progress to proximal DVT or even PE [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. Isolated calf muscular venous thrombosis (ICMVT), the most common form of distal DVT [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], is more prevalent in clinical practice than proximal DVT. Reports suggest that PE is not uncommon at the initial ICMVT diagnosis, and interim follow-ups reveal that 18.8% of patients experience at least one venous thromboembolism (VTE) recurrence [<xref ref-type="bibr" rid="CR11">11</xref>]. Other studies have reported that ICMVT is found in 23&#8211;41% of patients suspected of having DVT and in 47&#8211;79% of patients with confirmed DVT [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, the reports on ICMVT after TPF surgery were very limited. More attention should be given to the root causes of ICMVT, and immediate intervention is necessary to prevent or delay the onset and progression of ICMVT.</p><p id="Par19">In this retrospective study, we collected clinical data from patients with TPFs treated in our department to determine the incidence of ICMVT after TPFs, identify related risk factors, and evaluate their predictive capacity for ICMVT. This information could guide clinical practice and promote effective preventive strategies for this condition.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par20">All data for this investigation were retrieved from the TPFs database of our hospital. We retrospectively collected inpatient data from TPF patients who received surgical intervention in our hospital from March 2017 to March 2021 and conducted follow-ups via telephone questionnaires to assess patient recovery information. At present, there is no unified understanding of whether anticoagulant therapy is required for ICMVT [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], so we conducted Caprini scores for hospitalized patients with TPFs and only provided corresponding anticoagulant therapy for the patients with high risk before surgery [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Eligible patients were diagnosed with ICMVT via Color Duplex Flow Imager (CDFI) on the second post-operation day and provided complementary anticoagulant therapy based on their conditions [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><sec id="Sec3"><title>Inclusion and exclusion criteria</title><p id="Par21">The following patients were included for analysis: 1. age&#8201;&#8805;&#8201;18&#160;years old, undergoing TPFs surgery in our facility, and complete available hospitalization data; 2. Postoperative CDFI only revealed ICMVT. The following patients were eliminated from the analysis: 1. Pathological or old TPF (closure time from injury to surgery&#8201;&gt;&#8201;three weeks); 2. Combined with other fractures requiring surgery (except fibula fractures); 3. The affected knee joint received prior surgical intervention; 4. Prior history of thrombosis and receiving anticoagulant therapy; 5. With venous thrombosis, as indicated by preoperative examination; 6. Unable to complete follow-up.</p></sec><sec id="Sec4"><title>Data collection</title><p id="Par22">We queried data from the institutional electronic medical records of 615 patients who underwent TPFs surgery at our hospital between March 2017 and March 2021. Based on the inclusion and exclusion criteria, 481 patients were ultimately recruited for analysis. Based on venous thrombosis studies conducted by other researchers, we focused on the data that primarily determined ICMVT, as follows [<xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>]:<list list-type="order"><list-item><p id="Par23">Demographic TPFs characteristics include gender, age, body mass index (BMI), and left and right sides of the affected limb.</p></list-item><list-item><p id="Par24">Preoperative morbidity: These included hypertension, diabetes, open fractures, and blisters, as well as a history of surgery on the affected limb.</p></list-item><list-item><p id="Par25">Fracture classification: We used the Schatzker classification based on the comprehensive preoperative X-ray and CT three-dimensional reconstruction. These were performed by two experienced orthopedic surgeons, according to the imaging data obtained during admission. Any controversial grading was resolved through discussions among the aforementioned orthopedic surgeons. Patients were then separated into two cohorts, based on their degree of injury: Cohort 1 exhibited simple fractures (Schatzker type I-III), whereas Cohort 2 exhibited complex fractures (Schatzker type IV-VI) [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p></list-item><list-item><p id="Par26">Operational details: In this study, all patients were fitted with an inflatable tourniquet, set at a pressure of 40kpa, at the root of the thigh on the affected limb. The surgical duration was registered according to the operation records in the case system.</p></list-item><list-item><p id="Par27">Laboratory indicators: The following parameters were measured upon admission: total protein, albumin, alkaline phosphatase, lactate dehydrogenase, total bilirubin, direct bilirubin, indirect bilirubin, total cholesterol, triglyceride, red blood cell count, and white blood cell count at admission. In addition, the neutrophil count, lymphocyte count, monocyte, hemoglobin level, hematocrit, platelet, fasting blood glucose, sodium concentration, potassium concentration, chlorine concentration, calcium concentration, and D -Dimer.</p></list-item><list-item><p id="Par28">Lastly, the American Hospital for Special Surgery (HSS) score was measured during telephone-based follow-ups, and at the final outpatient visit. Imaging data were analyzed using the Rasmussen score at the last review (&#8805;&#8201;18&#160;months).</p></list-item></list></p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par29">The SPSS software was employed for all data analyses. The enumeration data are given as the mean&#8201;&#177;&#8201;standard deviation (SD). The inter-group comparisons were made via the independent sample t- or Mann&#8211;Whitney U test. Categorical variables were compared using the chi-square or Fisher&#8217;s exact test and are presented as absolute values and percentages. The multivariate analysis was employed for the analysis of single factors with <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.10 or those mentioned in other studies as influencing thrombosis, and the results are presented using a binary logistic regression model as odds ratio (OR) values and 95% confidence intervals (95% CI). The Hosmer&#8212;Lemeshow (H&#8212;L) test evaluated the final model&#8217;s reasonable degree, and <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05 was adjusted as the significance threshold.</p></sec></sec><sec id="Sec6"><title>Results</title><p id="Par30">Overall, we enrolled 481 patients, comprising 232 males (48.2%) and 249 females (51.8%), with a mean age of 51.2&#8201;&#177;&#8201;13.6&#160;years (range 18&#8211;87&#160;years). Among them, 26 (5.4%) had open fractures, and 22 (4.6%) had a preoperative blister. There were 47 cases (9.8%) of ICMVT, including 27 cases (57.4%) on the left and 20 cases (42.6%) on the right side. The population epidemiological data and single-factor analysis results are shown in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Summary of demographic data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Variables</bold></th><th align="left" colspan="1" rowspan="1"><bold>Number (%) of ICMVT (47)</bold></th><th align="left" colspan="1" rowspan="1"><bold>Number (%) of non-ICMVT (434)</bold></th><th align="left" colspan="1" rowspan="1"><bold>Total</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Gender (male)</td><td align="left" colspan="1" rowspan="1">12(22.7%)</td><td align="left" colspan="1" rowspan="1">220(50.7%)</td><td align="left" colspan="1" rowspan="1">232(48.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">58.3&#8201;&#177;&#8201;11.7</td><td align="left" colspan="1" rowspan="1">50.5&#8201;&#177;&#8201;13.6</td><td align="left" colspan="1" rowspan="1">51.2&#8201;&#177;&#8201;13.6</td></tr><tr><td align="left" colspan="1" rowspan="1">Preoperative duration (day)</td><td align="left" colspan="1" rowspan="1">5.5&#8201;&#177;&#8201;3.6</td><td align="left" colspan="1" rowspan="1">5.1&#8201;&#177;&#8201;2.7</td><td align="left" colspan="1" rowspan="1">5.5&#8201;&#177;&#8201;3.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Operation time</td><td align="left" colspan="1" rowspan="1">166.9&#8201;&#177;&#8201;59.9</td><td align="left" colspan="1" rowspan="1">134.4&#8201;&#177;&#8201;58.5</td><td align="left" colspan="1" rowspan="1">137.6&#8201;&#177;&#8201;59.3</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">24.3&#8201;&#177;&#8201;2.4</td><td align="left" colspan="1" rowspan="1">24.8&#8201;&#177;&#8201;3.0</td><td align="left" colspan="1" rowspan="1">24.8&#8201;&#177;&#8201;3.0</td></tr><tr><td align="left" colspan="1" rowspan="1">Open fractures(yes)</td><td align="left" colspan="1" rowspan="1">0(0%)</td><td align="left" colspan="1" rowspan="1">26(6%)</td><td align="left" colspan="1" rowspan="1">26(5.4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Blister(yes)</td><td align="left" colspan="1" rowspan="1">2(4.3%)</td><td align="left" colspan="1" rowspan="1">20(4.6%)</td><td align="left" colspan="1" rowspan="1">22(4.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension(yes)</td><td align="left" colspan="1" rowspan="1">14(29.8%)</td><td align="left" colspan="1" rowspan="1">108(24.9%)</td><td align="left" colspan="1" rowspan="1">122(25.4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes(yes)</td><td align="left" colspan="1" rowspan="1">4(8.5%)</td><td align="left" colspan="1" rowspan="1">44(10.1%)</td><td align="left" colspan="1" rowspan="1">48(10.0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Fibula fracture(yes)</td><td align="left" colspan="1" rowspan="1">17(36.2%)</td><td align="left" colspan="1" rowspan="1">131(30.2%)</td><td align="left" colspan="1" rowspan="1">148(30.8%)</td></tr><tr><td align="left" colspan="4" rowspan="1">Left and right sides</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Left</td><td align="left" colspan="1" rowspan="1">27(57.4)</td><td align="left" colspan="1" rowspan="1">269(62%)</td><td align="left" colspan="1" rowspan="1">296(61.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Right</td><td align="left" colspan="1" rowspan="1">20(42.6%)</td><td align="left" colspan="1" rowspan="1">165(38%)</td><td align="left" colspan="1" rowspan="1">185(38.5%)</td></tr><tr><td align="left" colspan="4" rowspan="1">Fracture type (Schatzker)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;I-III</td><td align="left" colspan="1" rowspan="1">20(42.6%)</td><td align="left" colspan="1" rowspan="1">225(51.8%)</td><td align="left" colspan="1" rowspan="1">245(50.9%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;IV-VI</td><td align="left" colspan="1" rowspan="1">27(57.4%)</td><td align="left" colspan="1" rowspan="1">209(48.2%)</td><td align="left" colspan="1" rowspan="1">236(49.1%)</td></tr><tr><td align="left" colspan="1" rowspan="1">WBC&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">23(48.9%)</td><td align="left" colspan="1" rowspan="1">112(25.8%)</td><td align="left" colspan="1" rowspan="1">135(28.1%)</td></tr><tr><td align="left" colspan="1" rowspan="1">RBC&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">10(21.3%)</td><td align="left" colspan="1" rowspan="1">80(18.4%)</td><td align="left" colspan="1" rowspan="1">90(18.7%)</td></tr><tr><td align="left" colspan="1" rowspan="1">HCT&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">37(78.7%)</td><td align="left" colspan="1" rowspan="1">264(60.8%)</td><td align="left" colspan="1" rowspan="1">301(62.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1">LYM(&lt;&#8201;1.1&#8201;&#215;&#8201;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">14(29.8%)</td><td align="left" colspan="1" rowspan="1">85(19.6%)</td><td align="left" colspan="1" rowspan="1">99(20.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1">MON(&gt;&#8201;0.6&#8201;&#215;&#8201;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">17(36.2%)</td><td align="left" colspan="1" rowspan="1">190(43.8%)</td><td align="left" colspan="1" rowspan="1">207(43.0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">NEUT(&gt;&#8201;6.3&#8201;&#215;&#8201;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">26(55.3%)</td><td align="left" colspan="1" rowspan="1">154(35.5%)</td><td align="left" colspan="1" rowspan="1">180(37.4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">PLT(&gt;&#8201;300&#8201;&#215;&#8201;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">1(2.1%)</td><td align="left" colspan="1" rowspan="1">29(6.7%)</td><td align="left" colspan="1" rowspan="1">30(6.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1">TBil(&gt;&#8201;21 umol/L)</td><td align="left" colspan="1" rowspan="1">11(23.4%)</td><td align="left" colspan="1" rowspan="1">74(17.1%)</td><td align="left" colspan="1" rowspan="1">85(17.7%)</td></tr><tr><td align="left" colspan="1" rowspan="1">DBil(&gt;&#8201;6 umol/L)</td><td align="left" colspan="1" rowspan="1">17(36.2%)</td><td align="left" colspan="1" rowspan="1">161(37.1%)</td><td align="left" colspan="1" rowspan="1">178(37.0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">IBil(&gt;&#8201;14 umol/L)</td><td align="left" colspan="1" rowspan="1">10(21.3%)</td><td align="left" colspan="1" rowspan="1">67(15.4%)</td><td align="left" colspan="1" rowspan="1">77(16.0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">TC(&gt;&#8201;5.2&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">9(19.1%)</td><td align="left" colspan="1" rowspan="1">64(14.7%)</td><td align="left" colspan="1" rowspan="1">73(15.2%)</td></tr><tr><td align="left" colspan="1" rowspan="1">TG(&gt;&#8201;1.7&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">8(17.0%)</td><td align="left" colspan="1" rowspan="1">88(20.3%)</td><td align="left" colspan="1" rowspan="1">96(20.0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">TP(&lt;&#8201;60&#160;g/L)</td><td align="left" colspan="1" rowspan="1">5(10.6%)</td><td align="left" colspan="1" rowspan="1">58(13.4%)</td><td align="left" colspan="1" rowspan="1">63(13.1%)</td></tr><tr><td align="left" colspan="1" rowspan="1">ALB(&lt;&#8201;35&#160;g/L)</td><td align="left" colspan="1" rowspan="1">4(8.5%)</td><td align="left" colspan="1" rowspan="1">28(6.5%)</td><td align="left" colspan="1" rowspan="1">32(6.7%)</td></tr><tr><td align="left" colspan="1" rowspan="1">ALP(&gt;&#8201;100)</td><td align="left" colspan="1" rowspan="1">8(17.0%)</td><td align="left" colspan="1" rowspan="1">48(11.1%)</td><td align="left" colspan="1" rowspan="1">56(11.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1">LDH(&gt;&#8201;250 U/L)</td><td align="left" colspan="1" rowspan="1">3(6.4%)</td><td align="left" colspan="1" rowspan="1">25(5.8%)</td><td align="left" colspan="1" rowspan="1">28(5.8%)</td></tr><tr><td align="left" colspan="1" rowspan="1">FBG(&gt;&#8201;6.1&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">23(48.9%)</td><td align="left" colspan="1" rowspan="1">148(34.1%)</td><td align="left" colspan="1" rowspan="1">171 (35.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1">K<sup>+</sup>(&lt;&#8201;3.5&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">10(21.3%)</td><td align="left" colspan="1" rowspan="1">58(13.4%)</td><td align="left" colspan="1" rowspan="1">68(14.1%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Na<sup>+</sup>(&lt;&#8201;135&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">11(23.4%)</td><td align="left" colspan="1" rowspan="1">53(12.2%)</td><td align="left" colspan="1" rowspan="1">64(13.3%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Ca<sup>2+</sup>(&lt;&#8201;2.25&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">27(57.4%)</td><td align="left" colspan="1" rowspan="1">250(57.6%)</td><td align="left" colspan="1" rowspan="1">277 (57.6%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Cl<sup>&#8722;</sup>(&lt;&#8201;96.0&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">1(2.1%)</td><td align="left" colspan="1" rowspan="1">17(3.9%)</td><td align="left" colspan="1" rowspan="1">18(3.7%)</td></tr><tr><td align="left" colspan="1" rowspan="1">D-Dimer(&gt;&#8201;0.50&#160;mg/L)</td><td align="left" colspan="1" rowspan="1">47(100%)</td><td align="left" colspan="1" rowspan="1">427(98.4%)</td><td align="left" colspan="1" rowspan="1">474 (98.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1">HBG&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">2(4.3%)</td><td align="left" colspan="1" rowspan="1">39(9.0%)</td><td align="left" colspan="1" rowspan="1">41(8.5%)</td></tr><tr><td align="left" colspan="1" rowspan="1">HSS</td><td align="left" colspan="1" rowspan="1">84.8&#8201;&#177;&#8201;8.2</td><td align="left" colspan="1" rowspan="1">87.6&#8201;&#177;&#8201;8.2</td><td align="left" colspan="1" rowspan="1">87.3&#8201;&#177;&#8201;8.2</td></tr><tr><td align="left" colspan="1" rowspan="1">Rasmussen</td><td align="left" colspan="1" rowspan="1">15.5&#8201;&#177;&#8201;1.6</td><td align="left" colspan="1" rowspan="1">16.0&#8201;&#177;&#8201;1.7</td><td align="left" colspan="1" rowspan="1">16.0&#8201;&#177;&#8201;1.7</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">BMI</italic> Body mass index, <italic toggle="yes">RBC</italic> Red blood cell, reference range: females, 3.5&#8211;5.5*10<sup>12</sup>/L; males, 4.0&#8211;5.5*10<sup>12</sup>/L. <italic toggle="yes">WBC</italic> White blood cell, reference range: 4&#8211;10*10<sup>9</sup>/L; <italic toggle="yes">HCT</italic> Hematocrit, reference range: females, 35%-45%; males, 40%-50%. <italic toggle="yes">LYM</italic> Lymphocyte, <italic toggle="yes">MON</italic> Monocyte count, <italic toggle="yes">NEUT</italic> Neutrophile, <italic toggle="yes">PLT</italic> Platelet, 100&#8211;300*10<sup>9</sup>/L; <italic toggle="yes">TBIL</italic> Total bilirubin, <italic toggle="yes">DBIL</italic> Direct bilirubin, <italic toggle="yes">IBIL</italic> Indirect bilirubin, <italic toggle="yes">TC</italic> Total cholesterol, <italic toggle="yes">TG</italic> Triglyceride, <italic toggle="yes">TP</italic> Total protein, <italic toggle="yes">ALB</italic> Albumin, <italic toggle="yes">ALP</italic> Alkaline phosphatase, <italic toggle="yes">LDH</italic> Lactate dehydrogenase, <italic toggle="yes">FBG</italic> Fasting blood glucose, <italic toggle="yes">HGB</italic> Hemoglobin, reference range: females, 110&#8211;150&#160;g/L; males, 120&#8211;160&#160;g/L, <italic toggle="yes">Na</italic><sup><italic toggle="yes">+</italic></sup> Sodium concentration, <italic toggle="yes">K</italic><sup><italic toggle="yes">+</italic></sup> Potassium concentration, <italic toggle="yes">Cl</italic><sup><italic toggle="yes">&#8722;</italic></sup> Chlorine concentration, <italic toggle="yes">Ca</italic><sup><italic toggle="yes">2+</italic></sup> Calcium concentration. <italic toggle="yes">HSS</italic> The American Hospital for Special Surgery</p></table-wrap-foot></table-wrap><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>The ICMVT-based risk factor after tibial plateau fractures surgery according to univariate analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Variables</bold></th><th align="left" colspan="1" rowspan="1"><bold>Number (%) of ICMVT (47)</bold></th><th align="left" colspan="1" rowspan="1"><bold>Number (%) of non-ICMVT (434)</bold></th><th align="left" colspan="1" rowspan="1"><bold><italic toggle="yes">P</italic></bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Gender (male)</td><td align="left" colspan="1" rowspan="1">12(22.7%)</td><td align="left" colspan="1" rowspan="1">220(50.7%)</td><td align="left" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">58.3&#8201;&#177;&#8201;11.7</td><td align="left" colspan="1" rowspan="1">50.5&#8201;&#177;&#8201;13.6</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;55&#160;years old</td><td align="left" colspan="1" rowspan="1">30(63.8%)</td><td align="left" colspan="1" rowspan="1">166(38.2%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Operation time</td><td align="left" colspan="1" rowspan="1">166.9&#8201;&#177;&#8201;59.9</td><td align="left" colspan="1" rowspan="1">134.4&#8201;&#177;&#8201;58.5</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;114&#160;min</td><td align="left" colspan="1" rowspan="1">38(80.9%)</td><td align="left" colspan="1" rowspan="1">237(54.6%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Open fractures(yes)</td><td align="left" colspan="1" rowspan="1">0(0%)</td><td align="left" colspan="1" rowspan="1">26(6%)</td><td align="left" colspan="1" rowspan="1">0.096</td></tr><tr><td align="left" colspan="1" rowspan="1">WBC&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">23(48.9%)</td><td align="left" colspan="1" rowspan="1">112(25.8%)</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">HCT&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">37(78.7%)</td><td align="left" colspan="1" rowspan="1">264(60.8%)</td><td align="left" colspan="1" rowspan="1">0.016</td></tr><tr><td align="left" colspan="1" rowspan="1">NEUT(&gt;&#8201;6.3&#8201;&#215;&#8201;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">26(55.3%)</td><td align="left" colspan="1" rowspan="1">154(35.5%)</td><td align="left" colspan="1" rowspan="1">0.008</td></tr><tr><td align="left" colspan="1" rowspan="1">FBG(&gt;&#8201;6.1&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">23(48.9%)</td><td align="left" colspan="1" rowspan="1">148(34.1%)</td><td align="left" colspan="1" rowspan="1">0.044</td></tr><tr><td align="left" colspan="1" rowspan="1">Na<sup>+</sup>(&lt;&#8201;135&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">11(23.4%)</td><td align="left" colspan="1" rowspan="1">53(12.2%)</td><td align="left" colspan="1" rowspan="1">0.032</td></tr><tr><td align="left" colspan="1" rowspan="1">D-Dimer(&gt;&#8201;0.50&#160;mg/L)</td><td align="left" colspan="1" rowspan="1">47(100%)</td><td align="left" colspan="1" rowspan="1">427(98.4%)</td><td align="left" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">HSS</td><td align="left" colspan="1" rowspan="1">84.8&#8201;&#177;&#8201;8.2</td><td align="left" colspan="1" rowspan="1">87.6&#8201;&#177;&#8201;8.2</td><td align="left" colspan="1" rowspan="1">0.014</td></tr><tr><td align="left" colspan="1" rowspan="1">Rasmussen</td><td align="left" colspan="1" rowspan="1">15.5&#8201;&#177;&#8201;1.6</td><td align="left" colspan="1" rowspan="1">16.0&#8201;&#177;&#8201;1.7</td><td align="left" colspan="1" rowspan="1">0.031</td></tr></tbody></table></table-wrap></p><p id="Par31">The age and surgical duration of the ICMVT cohort were markedly elevated compared to the non-ICMVT cohort (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Given the impact of patient age and surgical duration on ICMVT, we generated receiver operating characteristic (ROC) curves to determine the optimal threshold values for age and surgical duration to predict ICMVT. In addition, we employed area under curve (AUC) analysis to assess the significance of the ROC curve (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>a, b). As shown in Table <xref rid="Tab1" ref-type="table">1</xref>, significant differences were observed between the ICMVT and non-ICMVT cohorts regarding gender (<italic toggle="yes">p</italic>&#8201;=&#8201;0.001), age (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), surgical duration (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), white blood cell (WBC) count (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), elevated neutrophils levels (<italic toggle="yes">p</italic>&#8201;=&#8201;0.008), hyponatremia (<italic toggle="yes">p</italic>&#8201;=&#8201;0.032), fasting blood glucose (<italic toggle="yes">p</italic>&#8201;=&#8201;0.044), and hematocrit levels (<italic toggle="yes">p</italic>&#8201;=&#8201;0.016). Next, the baseline variables that reached significance in univariate analysis were entered into multivariate analysis. The eligible variables were carefully selected, given the number of available events, to ensure the parsimony of the final model [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>]. Finally, the D-Dimer level (<italic toggle="yes">p</italic>&#8201;=&#8201;1.000), the presence of an open fracture (<italic toggle="yes">p</italic>&#8201;=&#8201;0.096), and the previously mentioned eight variables were incorporated into the binary logistic regression model (Table <xref rid="Tab3" ref-type="table">3</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p><bold>A</bold> The ROC curve analysis revealed that, at a cutoff point of 55.5&#160;years old, the sensitivity and specificity of age in predicting ICMVT were 0.64 and 0.62, respectively, and the area under the curve (AUC) was 0.66. <bold>B</bold> At a cutoff point of 114.5&#160;min, the sensitivity and specificity of surgical duration in predicting ICMVT were 0.81 and 0.45, respectively, and the AUC was 0.67</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12891_2023_6764_Fig1_HTML.jpg"/></fig><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Multivariate assessment of ICMVT-related factors after tibial plateau fractures</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Variables</bold></th><th align="left" colspan="1" rowspan="1"><bold>OR</bold></th><th align="left" colspan="1" rowspan="1"><bold>95%CI</bold></th><th align="left" colspan="1" rowspan="1"><bold><italic toggle="yes">P</italic></bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age(&gt;&#8201;55&#160;years old)</td><td align="left" colspan="1" rowspan="1">3.06</td><td align="left" colspan="1" rowspan="1">1.47&#8211;6.37</td><td align="left" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">Gender(female)</td><td align="left" colspan="1" rowspan="1">2.67</td><td align="left" colspan="1" rowspan="1">1.37&#8211;5.22</td><td align="left" colspan="1" rowspan="1">0.004</td></tr><tr><td align="left" colspan="1" rowspan="1">Surgical duration(&gt;&#8201;114&#160;min)</td><td align="left" colspan="1" rowspan="1">3.14</td><td align="left" colspan="1" rowspan="1">1.44&#8211;6.85</td><td align="left" colspan="1" rowspan="1">0.004</td></tr><tr><td align="left" colspan="1" rowspan="1">WBC&#8201;&lt;&#8201;lower limit</td><td align="left" colspan="1" rowspan="1">2.85</td><td align="left" colspan="1" rowspan="1">1.47&#8211;5.51</td><td align="left" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">Na<sup>+</sup>(&lt;&#8201;135&#160;mmol/L)</td><td align="left" colspan="1" rowspan="1">2.31</td><td align="left" colspan="1" rowspan="1">1.04&#8211;5.12</td><td align="left" colspan="1" rowspan="1">0.040</td></tr></tbody></table><table-wrap-foot><p>Numbers are significant at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, <italic toggle="yes">OR</italic> Odds ratio, <italic toggle="yes">CI</italic> Confidence interval. <italic toggle="yes">WBC</italic> White blood cell, reference range: 4&#8211;10*109/L. (Open fracture, <italic toggle="yes">p</italic>&#8201;=&#8201;0.60; <italic toggle="yes">NEUT</italic> Neutrophile, <italic toggle="yes">p</italic>&#8201;=&#8201;0.079; D-Dimer, <italic toggle="yes">p</italic>&#8201;=&#8201;0.545; <italic toggle="yes">HCT</italic> Hematocrit, <italic toggle="yes">p</italic>&#8201;=&#8201;0.189)</p></table-wrap-foot></table-wrap></p><p id="Par32">We identified five ICMVT-related RFs in the final analysis: age (&gt;&#8201;55&#160;years old) (OR 3.06; 95% CI 1.47&#8211;6.37; <italic toggle="yes">p</italic>&#8201;=&#8201;0.003), gender (female) (OR 2.67; 95% CI 1.37&#8211;5.22; <italic toggle="yes">p</italic>&#8201;=&#8201;0.004), surgical duration (&gt;&#8201;114&#160;min) (OR 3.14; 95% CI 1.44&#8211;6.85; <italic toggle="yes">p</italic>&#8201;=&#8201;0.004), elevated WBC count (OR 2.85; 95% CI 1.47&#8211;5.51; <italic toggle="yes">p</italic>&#8201;=&#8201;0.002), and hyponatremia (OR 2.31; 95% CI 1.04&#8211;5.12; <italic toggle="yes">p</italic>&#8201;=&#8201;0.040). Moreover, the H&#8211;L test revealed that the final model displayed an elevated degree of fit (<italic toggle="yes">X</italic><sup>2</sup>&#8201;=&#8201;5.03, <italic toggle="yes">p</italic>&#8201;=&#8201;0.75; Nagelkerke <italic toggle="yes">R</italic><sup>2</sup>&#8201;=&#8201;0.20).</p></sec><sec id="Sec7"><title>Discussion</title><p id="Par33">This study revealed that the patient age (&gt;&#8201;55&#160;years old), gender (female), surgical duration (&gt;&#8201;114&#160;min), elevated WBC levels, and hyponatremia (&lt;&#8201;135&#160;mmol/L) were independent RFs for postoperative ICMVT occurrence in patients with TPFs. The HSS and Rasmussen scores of patients with ICMVT were significantly lower than those without ICMVT (<italic toggle="yes">p</italic>&#8201;=&#8201;0.014, <italic toggle="yes">p</italic>&#8201;=&#8201;0.031).</p><p id="Par34">The displacement fracture of the tibial plateau and operation may lead to popliteal vascular injury, an important factor for the formation of popliteal vein thrombus, a form of proximal DVT. With increasing awareness of the serious hazards of DVT, various measures have been taken for DVT prophylaxis, such as low molecular weight heparin, graduated compression stockings, and intermittent pneumatic compression devices. The incidence of proximal DVT has dropped significantly. In the past four years, only four patients with TPFs developed proximal DVT in our hospital, and the incidence was 0.83%. In contrast, the incidence of postoperative ICMVT was 9.8%, which is considerably higher than proximal DVT, a conclusion supported by previous research [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref>]. The occurrence of ICMVT is more common in clinical practice, and due to the possibility of further progress, further analysis of its epidemiological data is needed. Therefore, we mainly analyzed patients with postoperative ICMVT. Four of the 47 patients diagnosed with postoperative ICMVT exhibited sudden swelling of the affected limb. Based on the CDFI, ICMVT was suggested. The symptoms of 4 patients were alleviated upon anticoagulation adjustment, and no thrombosis was evident one month after surgery. All ICMVTs occurred on the affected side, which may result from the vascular endothelial injury caused by the trauma and surgery on the affected side, as well as the systemic hypercoagulation state and extremity swelling due to fracture surgery.</p><p id="Par35">This study considered age (<italic toggle="yes">p</italic>&#8201;=&#8201;0.003) as an independent RF for ICMVT. Based on the ROC curve analysis for age, the optimal threshold was 55.5&#160;years old. It carried a sensitivity of 0.64 and specificity of 0.62, thus, indicating the enhanced predictability of age in predicting ICMVT after TPFs surgery. Similar results were confirmed in the study of Li et al. [<xref ref-type="bibr" rid="CR21">21</xref>]. The average age of patients in their study was 45.2&#160;years old, compared with 51.2&#160;years old in ours, which makes our threshold higher than other studies have found. This may potentially be due to the alterations in blood components that occur with age, which may, in turn, favor thrombus clotting. This suggests that ICMVT may be more common in older patients with fractures [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par36">Prolonged surgical duration (<italic toggle="yes">p</italic>&#8201;=&#8201;0.004) was also found to be correlated with postoperative ICMVT development in this study. The optimal threshold, as evidenced by the ROC curve, was 114.5&#160;min. Above this critical value, the postoperative ICMVT risk increased. It is well established that thrombus formation requires three factors: venous blood flow stasis, vascular endothelial injury, and blood hypercoagulability [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Due to the application of a tourniquet, blood stasis can occur within the veins, thereby decreasing blood flow velocity during surgery. Meanwhile, the operation is a form of trauma. The trauma- and anesthesia-associated stress and inflammatory response often damage the vascular endothelium. Studies involving routine emergency surgical procedures reported that prolonged surgical duration is closely related to VTE [<xref ref-type="bibr" rid="CR34">34</xref>]. Li et al. also revealed that DVT formation after TPF is correlated with the prolongation of operation duration [<xref ref-type="bibr" rid="CR21">21</xref>]. In this study, the ROC curve was used to determine the critical value of operation time, beyond which the probability of postoperative thrombosis increased, which was the same as the conclusion of previous studies. Therefore, we concluded that a prolonged surgical duration might be one of the RFs for lower extremity ICMVT.</p><p id="Par37">Along with demographic indicators, we also demonstrated an association between hyponatremia, elevated WBC count, and postoperative ICMVT. Several studies reported that hyponatremia impacts venous thrombosis before and after TPFs, in which the cause of hyponatremia was not well elucidated. Based on reports in other relevant literature, we speculated that hyponatremia might be related to the patient&#8217;s morbidity and inflammatory response. The study showed patient morbidities, such as cardiac or renal insufficiency and alteration of blood flow status, accompanied by hyponatremia and patients with hyponatremia had a higher rate of new fractures [<xref ref-type="bibr" rid="CR35">35</xref>]. Hyponatremia was reported to be significantly correlated with inflammatory response [<xref ref-type="bibr" rid="CR36">36</xref>]. Previous studies reported that inflammatory responses were related to thrombosis formation [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref>]. In addition, Liu et al. concluded that an enhanced neutrophil content was significantly associated with venous thrombosis formation after TPFs [<xref ref-type="bibr" rid="CR28">28</xref>]. However, our study results did not reflect this conclusion (<italic toggle="yes">p</italic>&#8201;=&#8201;0.079). In this investigation, elevated WBC levels were strongly associated with ICMVT after TPFs (<italic toggle="yes">p</italic>&#8201;=&#8201;0.002). WBC is prominent participants in inflammatory development and is closely related to whole body inflammation [<xref ref-type="bibr" rid="CR40">40</xref>]. On the other hand, WBC primarily took part in forming the front edge of the thrombus, and they promote further thrombosis development using tissue factors [<xref ref-type="bibr" rid="CR41">41</xref>]. Therefore, an increase in WBC after a tibial plateau fracture may accelerate thrombus formation.</p><p id="Par38">In our findings, the HSS scores (87.6&#8201;&#177;&#8201;8.2) and Rasmussen scores (16.0&#8201;&#177;&#8201;1.7) of patients without ICMVT were significantly different from those of patients with ICMVT (84.8&#8201;&#177;&#8201;8.2, 15.5&#8201;&#177;&#8201;1.6) (<italic toggle="yes">p</italic>&#8201;=&#8201;0.014, <italic toggle="yes">p</italic>&#8201;=&#8201;0.031). Several earlier reports suggested that the HSS score was strongly associated with TPFs classification [<xref ref-type="bibr" rid="CR42">42</xref>]. However, concerning the ICMVT incidence, we found no significant difference between complex and simple fractures based on the Schatzker stratification (<italic toggle="yes">p</italic>&#8201;=&#8201;0.226). Other studies also showed that fracture classification of the tibial plateau didn&#8217;t affect thrombus formation [<xref ref-type="bibr" rid="CR21">21</xref>]. Based on our results, the prognosis of patients with TPFs without ICMVT was better than the TPFs patients with ICMVT, thereby suggesting that ICMVT is a risk factor affecting patient prognosis. On the other hand, the Rasmussen imaging score is often related to fracture severity. Moreover, the Rasmussen score of patients with complex fractures is generally markedly lower than patients with simple fractures [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. In this investigation, the Rasmussen score was significantly distinct between with and without ICMVT cohorts. This evidence suggests that with more severe fractures, the surgical duration tends to be more prolonged, simultaneously increasing the incidence of ICMVT. However, there seems to be some contradiction, so further studies are required to verify the predictability of postoperative recovery in patients with TPFs.</p><p id="Par39">Previous studies on DVT mainly focus on the development of proximal DVT, including the direction of hip fracture, pelvic fracture, and hip and knee replacement. This study focuses on the analysis of distal DVT, which has a higher incidence following postoperative tibial plateau fractures, intending to personalize patient assessment and develop targeted prevention programs within the clinic.</p><p id="Par40">This investigation had certain limitations. Firstly, there was no consensus on the necessity of anticoagulants, and the thrombosis prevention approach after TPFs. Secondly, the impact of postoperative routine anticoagulation administration on ICMVT formation was not considered. Despite these limitations, the findings are useful for personalizing patient assessment and in developing targeted prevention programs within the clinic. Future studies will further explore the effect of prophylactic anticoagulation administration on the occurrence of ICMVT and the postoperative outcomes of TPFs.</p></sec><sec id="Sec8"><title>Conclusion</title><p id="Par41">This investigation revealed a 9.8% incidence of postoperative ICMVT in patients with TPFs, all occurring on the affected side. The HSS and Rasmussen scores in the non-ICMVT cohort were markedly enhanced, compared to the ICMVT cohort, indicating that the ICMVT may affect fracture prognosis. We identified five RFs: age, gender, prolonged surgical duration, elevated WBC levels, and hyponatremia.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>DVT</term><def><p id="Par5">Deep vein thrombosis</p></def></def-item><def-item><term>ICMVT</term><def><p id="Par6">Isolated calf muscular venous thrombosis</p></def></def-item><def-item><term>TPFs</term><def><p id="Par7">Tibial plateau fractures</p></def></def-item><def-item><term>RFs</term><def><p id="Par8">Risk factors</p></def></def-item><def-item><term>HSS</term><def><p id="Par9">The American Hospital for Special Surgery</p></def></def-item><def-item><term>CDFI</term><def><p id="Par10">Color Duplex Flow Imager</p></def></def-item><def-item><term>PE</term><def><p id="Par11">Pulmonary embolism</p></def></def-item><def-item><term>VTE</term><def><p id="Par12">Venous thromboembolism</p></def></def-item><def-item><term>OR</term><def><p id="Par13">Odds ratio</p></def></def-item><def-item><term>CI</term><def><p id="Par14">Confidence intervals</p></def></def-item><def-item><term>H&#8212;L</term><def><p id="Par15">Hosmer &#8211; Lemeshow</p></def></def-item><def-item><term>ROC</term><def><p id="Par16">Receiver operating characteristic</p></def></def-item><def-item><term>AUC</term><def><p id="Par17">Area under curve</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Jian Peng, Bin Feng and Weizhi Ren contributed equally to this work and should be considered co-first authors.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We appreciate the contribution of all patients, their families, the investigators, and the medical staff. We are grateful to all authors.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>Wei Xu conceived the idea for the study; Jian Peng, Bin Feng, and Weizhi Ren designed the study. Bin Feng, Weizhi Ren, Shijie Jiang, Chenying Wu, and Zhenghui Hu collected the relevant data and followed up with the patients. Jian Peng and Weizhi Ren prepared the figures and tables. Jian Peng performed the statistical analyses. All the authors interpreted the data and contributed to the preparation of the manuscript. The authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research was supported by the Natural Science Fund of China (81874008), the Soochow Health Program of talent training (GSWS2019010) and Suzhou key Disciplines (SZXK202104).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The authors confirm that the data supporting the findings of this study are available within the article.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par42">The study was carried out in accordance with the guidelines of the Declaration of Helsinki. This study was reviewed and approved by Ethics committee of the Second Affiliated Hospital of Soochow University. Informed consent was obtained from all individual participants included in the study. Written informed consent was obtained from all the participants for publish the data in open access journal.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par43">Not Application.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par44">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsoe</surname><given-names>R</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>P</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>NP</given-names></name><name name-style="western"><surname>Swenne</surname><given-names>J</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>S</given-names></name><name name-style="western"><surname>Ostgaard</surname><given-names>SE</given-names></name></person-group><article-title>Population-based epidemiology of tibial plateau fractures</article-title><source>Orthopedics</source><year>2015</year><volume>38</volume><issue>9</issue><fpage>e780</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.3928/01477447-20150902-55</pub-id><pub-id pub-id-type="pmid">26375535</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>YW</given-names></name><name name-style="western"><surname>Li</surname><given-names>YH</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L</given-names></name></person-group><article-title>Popliteal artery transection associated with a minimally displaced tibial plateau fracture: a case report and review of the literature</article-title><source>BMC Musculoskelet Disord</source><year>2020</year><volume>21</volume><issue>1</issue><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/s12891-020-3089-8</pub-id><pub-id pub-id-type="pmid">32000749</pub-id><pub-id pub-id-type="pmcid">PMC6993439</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andring</surname><given-names>N</given-names></name><name name-style="western"><surname>Olszewski</surname><given-names>C</given-names></name><name name-style="western"><surname>Strickland</surname><given-names>L</given-names></name><name name-style="western"><surname>Beck</surname><given-names>E</given-names></name><name name-style="western"><surname>Bang</surname><given-names>K</given-names></name><name name-style="western"><surname>Pilson</surname><given-names>H</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>E</given-names></name><name name-style="western"><surname>Halvorson</surname><given-names>J</given-names></name></person-group><article-title>No false elevation in ankle brachial index in patients with tibial plateau fractures and vascular risk factors</article-title><source>J Orthop</source><year>2022</year><volume>30</volume><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.jor.2022.02.019</pub-id><pub-id pub-id-type="pmid">35264825</pub-id><pub-id pub-id-type="pmcid">PMC8899118</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>T</given-names></name><name name-style="western"><surname>Buschmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Beyer</surname><given-names>J</given-names></name><name name-style="western"><surname>Halbritter</surname><given-names>K</given-names></name><name name-style="western"><surname>Rastan</surname><given-names>A</given-names></name><name name-style="western"><surname>Schellong</surname><given-names>S</given-names></name></person-group><article-title>Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study</article-title><source>J Vasc Surg</source><year>2010</year><volume>52</volume><issue>5</issue><fpage>1246</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2010.05.094</pub-id><pub-id pub-id-type="pmid">20630682</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masuda</surname><given-names>EM</given-names></name><name name-style="western"><surname>Kistner</surname><given-names>RL</given-names></name><name name-style="western"><surname>Musikasinthorn</surname><given-names>C</given-names></name><name name-style="western"><surname>Liquido</surname><given-names>F</given-names></name><name name-style="western"><surname>Geling</surname><given-names>O</given-names></name><name name-style="western"><surname>He</surname><given-names>Q</given-names></name></person-group><article-title>The controversy of managing calf vein thrombosis</article-title><source>J Vasc Surg</source><year>2012</year><volume>55</volume><issue>2</issue><fpage>550</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2011.05.092</pub-id><pub-id pub-id-type="pmid">22032881</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macdonald</surname><given-names>PS</given-names></name><name name-style="western"><surname>Kahn</surname><given-names>SR</given-names></name><name name-style="western"><surname>Miller</surname><given-names>N</given-names></name><name name-style="western"><surname>Obrand</surname><given-names>D</given-names></name></person-group><article-title>Short-term natural history of isolated gastrocnemius and soleal vein thrombosis</article-title><source>J Vasc Surg</source><year>2003</year><volume>37</volume><issue>3</issue><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1067/mva.2003.149</pub-id><pub-id pub-id-type="pmid">12618686</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>JC</given-names></name><name name-style="western"><surname>Satiani</surname><given-names>B</given-names></name></person-group><article-title>Calf muscle venous thrombosis: a review of the clinical implications and therapy</article-title><source>Vasc Endovascular Surg</source><year>2014</year><volume>48</volume><issue>5&#8211;6</issue><fpage>396</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1177/1538574414541704</pub-id><pub-id pub-id-type="pmid">25027613</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palareti</surname><given-names>G</given-names></name><name name-style="western"><surname>Schellong</surname><given-names>S</given-names></name></person-group><article-title>Isolated distal deep vein thrombosis: what we know and what we are doing</article-title><source>J Thromb Haemost</source><year>2012</year><volume>10</volume><issue>1</issue><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2011.04564.x</pub-id><pub-id pub-id-type="pmid">22082302</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gillet</surname><given-names>JL</given-names></name><name name-style="western"><surname>Perrin</surname><given-names>MR</given-names></name><name name-style="western"><surname>Allaert</surname><given-names>FA</given-names></name></person-group><article-title>Short-term and mid-term outcome of isolated symptomatic muscular calf vein thrombosis</article-title><source>J Vasc Surg</source><year>2007</year><volume>46</volume><issue>3</issue><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2007.04.040</pub-id><pub-id pub-id-type="pmid">17681715</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ro</surname><given-names>A</given-names></name><name name-style="western"><surname>Kageyama</surname><given-names>N</given-names></name><name name-style="western"><surname>Mukai</surname><given-names>T</given-names></name></person-group><article-title>Pathophysiology of venous thromboembolism with respect to the anatomical features of the deep veins of lower limbs: a review</article-title><source>Ann Vasc Dis</source><year>2017</year><volume>10</volume><issue>2</issue><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.3400/avd.ra.17-00035</pub-id><pub-id pub-id-type="pmid">29034034</pub-id><pub-id pub-id-type="pmcid">PMC5579784</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>A</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name></person-group><article-title>The outcome of isolated calf muscle vein thrombosis after open reduction and internal fixation for closed intra-articular distal femur fractures: a prospective cohort study</article-title><source>BMC Musculoskelet Disord</source><year>2021</year><volume>22</volume><issue>1</issue><fpage>397</fpage><pub-id pub-id-type="doi">10.1186/s12891-021-04289-3</pub-id><pub-id pub-id-type="pmid">33910542</pub-id><pub-id pub-id-type="pmcid">PMC8082779</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JW</given-names></name><name name-style="western"><surname>Weng</surname><given-names>LH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Yu</surname><given-names>PC</given-names></name></person-group><article-title>Clinical significance of muscular deep-vein thrombosis after total knee arthroplasty</article-title><source>Chang Gung Med J</source><year>2007</year><volume>30</volume><issue>1</issue><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1097/00029330-200701010-00008</pub-id><pub-id pub-id-type="pmid">17477028</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshimura</surname><given-names>N</given-names></name><name name-style="western"><surname>Hori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Horii</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takano</surname><given-names>T</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Aoyama</surname><given-names>H</given-names></name></person-group><article-title>Where is the most common site of DVT? Evaluation by CT venography</article-title><source>Jpn J Radiol</source><year>2012</year><volume>30</volume><issue>5</issue><fpage>393</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1007/s11604-012-0059-6</pub-id><pub-id pub-id-type="pmid">22367774</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galanaud</surname><given-names>JP</given-names></name><name name-style="western"><surname>Sevestre</surname><given-names>MA</given-names></name><name name-style="western"><surname>Genty</surname><given-names>C</given-names></name><name name-style="western"><surname>Laroche</surname><given-names>JP</given-names></name><name name-style="western"><surname>Zizka</surname><given-names>V</given-names></name><name name-style="western"><surname>Quere</surname><given-names>I</given-names></name><name name-style="western"><surname>Bosson</surname><given-names>JL</given-names></name><collab>investigators OS</collab></person-group><article-title>Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis</article-title><source>J Vasc Surg</source><year>2010</year><volume>52</volume><issue>4</issue><fpage>932</fpage><lpage>938, 938 e931-932</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2010.05.019</pub-id><pub-id pub-id-type="pmid">20630688</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>R</given-names></name><name name-style="western"><surname>Probeck</surname><given-names>K</given-names></name><name name-style="western"><surname>Elitharp</surname><given-names>DM</given-names></name><name name-style="western"><surname>Gasparis</surname><given-names>AP</given-names></name><name name-style="western"><surname>Labropoulos</surname><given-names>N</given-names></name></person-group><article-title>Diverse management of isolated calf deep venous thrombosis in a university hospital</article-title><source>J Vasc Surg Venous Lymphat Disord</source><year>2018</year><volume>6</volume><issue>2</issue><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.jvsv.2017.08.021</pub-id><pub-id pub-id-type="pmid">29229465</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luksameearunothai</surname><given-names>K</given-names></name><name name-style="western"><surname>Sa-Ngasoongsong</surname><given-names>P</given-names></name><name name-style="western"><surname>Kulachote</surname><given-names>N</given-names></name><name name-style="western"><surname>Thamyongkit</surname><given-names>S</given-names></name><name name-style="western"><surname>Fuangfa</surname><given-names>P</given-names></name><name name-style="western"><surname>Chanplakorn</surname><given-names>P</given-names></name><name name-style="western"><surname>Woratanarat</surname><given-names>P</given-names></name><name name-style="western"><surname>Suphachatwong</surname><given-names>C</given-names></name></person-group><article-title>Usefulness of clinical predictors for preoperative screening of deep vein thrombosis in hip fractures</article-title><source>BMC Musculoskelet Disord</source><year>2017</year><volume>18</volume><issue>1</issue><fpage>208</fpage><pub-id pub-id-type="doi">10.1186/s12891-017-1582-5</pub-id><pub-id pub-id-type="pmid">28532441</pub-id><pub-id pub-id-type="pmcid">PMC5440897</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krauss</surname><given-names>ES</given-names></name><name name-style="western"><surname>Segal</surname><given-names>A</given-names></name><name name-style="western"><surname>Cronin</surname><given-names>M</given-names></name><name name-style="western"><surname>Dengler</surname><given-names>N</given-names></name><name name-style="western"><surname>Lesser</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S</given-names></name><name name-style="western"><surname>Caprini</surname><given-names>JA</given-names></name></person-group><article-title>Implementation and validation of the 2013 Caprini score for risk stratification of arthroplasty patients in the prevention of venous thrombosis</article-title><source>Clin Appl Thromb Hemost</source><year>2019</year><volume>25</volume><fpage>1076029619838066</fpage><pub-id pub-id-type="doi">10.1177/1076029619838066</pub-id><pub-id pub-id-type="pmid">30939898</pub-id><pub-id pub-id-type="pmcid">PMC6714918</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lautz</surname><given-names>TB</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>F</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Chow</surname><given-names>C</given-names></name><name name-style="western"><surname>Amaranto</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>E</given-names></name><name name-style="western"><surname>Blackburn</surname><given-names>D</given-names></name><name name-style="western"><surname>Pearce</surname><given-names>WH</given-names></name><name name-style="western"><surname>Kibbe</surname><given-names>MR</given-names></name></person-group><article-title>Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation?</article-title><source>Ann Surg</source><year>2010</year><volume>251</volume><issue>4</issue><fpage>735</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e3181c1ae95</pub-id><pub-id pub-id-type="pmid">19858700</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>XC</given-names></name><name name-style="western"><surname>Hu</surname><given-names>XH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XR</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>CX</given-names></name><name name-style="western"><surname>Wang</surname><given-names>GY</given-names></name></person-group><article-title>Efficacy and safety of therapeutic anticoagulation for the treatment of isolated calf muscle vein thrombosis - a systematic review and meta-analysis</article-title><source>Vasa</source><year>2016</year><volume>45</volume><issue>6</issue><fpage>478</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1024/0301-1526/a000569</pub-id><pub-id pub-id-type="pmid">27598049</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Meng</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name></person-group><article-title>Incidence and locations of preoperative deep venous thrombosis (DVT) of lower extremity following tibial plateau fractures: a prospective cohort study</article-title><source>J Orthop Surg Res</source><year>2021</year><volume>16</volume><issue>1</issue><fpage>113</fpage><pub-id pub-id-type="doi">10.1186/s13018-021-02259-y</pub-id><pub-id pub-id-type="pmid">33546695</pub-id><pub-id pub-id-type="pmcid">PMC7863261</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Meng</surname><given-names>H</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ye</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Incidence and locations of deep venous thrombosis of the lower extremity following surgeries of tibial plateau fractures: a prospective cohort study</article-title><source>J Orthop Surg Res</source><year>2020</year><volume>15</volume><issue>1</issue><fpage>605</fpage><pub-id pub-id-type="doi">10.1186/s13018-020-02136-0</pub-id><pub-id pub-id-type="pmid">33317585</pub-id><pub-id pub-id-type="pmcid">PMC7735415</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tian</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Neutrophil to lymphocyte ratio and fracture severity in young and middle-aged patients with tibial plateau fractures</article-title><source>Int Orthop</source><year>2020</year><volume>44</volume><issue>12</issue><fpage>2769</fpage><lpage>2777</lpage><pub-id pub-id-type="doi">10.1007/s00264-020-04793-6</pub-id><pub-id pub-id-type="pmid">32897401</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiahao</surname><given-names>L</given-names></name><name name-style="western"><surname>Kun</surname><given-names>Z</given-names></name><name name-style="western"><surname>Binfei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hanzhong</surname><given-names>X</given-names></name><name name-style="western"><surname>Shuangwei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Na</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ding</surname><given-names>T</given-names></name><name name-style="western"><surname>Pengfei</surname><given-names>W</given-names></name></person-group><article-title>Relationship between the incidence of deep vein thrombosis during hospitalization and the energy of injury in tibial plateau fractures</article-title><source>Clin Appl Thromb Hemost</source><year>2020</year><volume>26</volume><fpage>1076029620913948</fpage><pub-id pub-id-type="doi">10.1177/1076029620913948</pub-id><pub-id pub-id-type="pmid">32988241</pub-id><pub-id pub-id-type="pmcid">PMC7545747</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>JB</given-names></name><name name-style="western"><surname>Tu</surname><given-names>CG</given-names></name><name name-style="western"><surname>Phan</surname><given-names>TM</given-names></name><name name-style="western"><surname>Rickman</surname><given-names>M</given-names></name><name name-style="western"><surname>Varghese</surname><given-names>VD</given-names></name><name name-style="western"><surname>Thewlis</surname><given-names>D</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>LB</given-names></name></person-group><article-title>Characteristics of postoperative weight bearing and management protocols for tibial plateau fractures: findings from a scoping review</article-title><source>Injury</source><year>2017</year><volume>48</volume><issue>12</issue><fpage>2634</fpage><lpage>2642</lpage><pub-id pub-id-type="doi">10.1016/j.injury.2017.10.040</pub-id><pub-id pub-id-type="pmid">29102370</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name></person-group><article-title>Association between hypertension and deep vein thrombosis after orthopedic surgery: a meta-analysis</article-title><source>Eur J Med Res</source><year>2016</year><volume>21</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s40001-016-0207-z</pub-id><pub-id pub-id-type="pmid">27004410</pub-id><pub-id pub-id-type="pmcid">PMC4802612</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edmonds</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Crichton</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Runciman</surname><given-names>WB</given-names></name><name name-style="western"><surname>Pradhan</surname><given-names>M</given-names></name></person-group><article-title>Evidence-based risk factors for postoperative deep vein thrombosis</article-title><source>ANZ J Surg</source><year>2004</year><volume>74</volume><issue>12</issue><fpage>1082</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1111/j.1445-1433.2004.03258.x</pub-id><pub-id pub-id-type="pmid">15574153</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>JR</given-names></name><name name-style="western"><surname>Little</surname><given-names>MT</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>PA</given-names></name><name name-style="western"><surname>Benirschke</surname><given-names>SK</given-names></name></person-group><article-title>Incidence of preoperative deep vein thrombosis in calcaneal fractures</article-title><source>J Orthop Trauma</source><year>2016</year><volume>30</volume><issue>7</issue><fpage>e242</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1097/BOT.0000000000000568</pub-id><pub-id pub-id-type="pmid">26913595</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Meng</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures</article-title><source>J Orthop Surg Res</source><year>2020</year><volume>15</volume><issue>1</issue><fpage>241</fpage><pub-id pub-id-type="doi">10.1186/s13018-020-01765-9</pub-id><pub-id pub-id-type="pmid">32616051</pub-id><pub-id pub-id-type="pmcid">PMC7331237</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Ueta</surname><given-names>T</given-names></name><name name-style="western"><surname>Shiba</surname><given-names>K</given-names></name><name name-style="western"><surname>Iwamoto</surname><given-names>Y</given-names></name></person-group><article-title>D-dimer screening for deep venous thrombosis in traumatic cervical spinal injuries</article-title><source>Spine J</source><year>2015</year><volume>15</volume><issue>11</issue><fpage>2338</fpage><lpage>2344</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2015.06.060</pub-id><pub-id pub-id-type="pmid">26130085</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>RS</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>AR</given-names></name><name name-style="western"><surname>Dalton</surname><given-names>JB</given-names></name><name name-style="western"><surname>Pai</surname><given-names>S</given-names></name><name name-style="western"><surname>McPherson</surname><given-names>RA</given-names></name></person-group><article-title>Widely used types and clinical applications of D-dimer assay</article-title><source>Lab Med</source><year>2016</year><volume>47</volume><issue>2</issue><fpage>90</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1093/labmed/lmw001</pub-id><pub-id pub-id-type="pmid">27016528</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lijfering</surname><given-names>WM</given-names></name><name name-style="western"><surname>Rosendaal</surname><given-names>FR</given-names></name><name name-style="western"><surname>Cannegieter</surname><given-names>SC</given-names></name></person-group><article-title>Risk factors for venous thrombosis - current understanding from an epidemiological point of view</article-title><source>Br J Haematol</source><year>2010</year><volume>149</volume><issue>6</issue><fpage>824</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.2010.08206.x</pub-id><pub-id pub-id-type="pmid">20456358</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turpie</surname><given-names>AG</given-names></name><name name-style="western"><surname>Chin</surname><given-names>BS</given-names></name><name name-style="western"><surname>Lip</surname><given-names>GY</given-names></name></person-group><article-title>Venous thromboembolism: pathophysiology, clinical features, and prevention</article-title><source>BMJ</source><year>2002</year><volume>325</volume><issue>7369</issue><fpage>887</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1136/bmj.325.7369.887</pub-id><pub-id pub-id-type="pmid">12386044</pub-id><pub-id pub-id-type="pmcid">PMC1124386</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Es</surname><given-names>N</given-names></name><name name-style="western"><surname>Ay</surname><given-names>C</given-names></name><name name-style="western"><surname>Jara-Palomares</surname><given-names>L</given-names></name></person-group><article-title>Screening for occult cancer in patients with venous thromboembolism: past, present, and future</article-title><source>Hamostaseologie</source><year>2020</year><volume>40</volume><issue>3</issue><fpage>270</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1055/a-1150-2286</pub-id><pub-id pub-id-type="pmid">32726822</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakran</surname><given-names>JV</given-names></name><name name-style="western"><surname>Ezzeddine</surname><given-names>H</given-names></name><name name-style="western"><surname>Haut</surname><given-names>ER</given-names></name><name name-style="western"><surname>Lunardi</surname><given-names>N</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>A</given-names></name><name name-style="western"><surname>Choron</surname><given-names>RL</given-names></name><name name-style="western"><surname>Reid</surname><given-names>J</given-names></name><name name-style="western"><surname>Zeeshan</surname><given-names>M</given-names></name><name name-style="western"><surname>Hamidi</surname><given-names>M</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>BA</given-names></name></person-group><article-title>Prolonged operating room time in emergency general surgery is associated with venous thromboembolic complications</article-title><source>Am J Surg</source><year>2019</year><volume>218</volume><issue>5</issue><fpage>836</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2019.04.022</pub-id><pub-id pub-id-type="pmid">31088627</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adrogue</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>BM</given-names></name><name name-style="western"><surname>Madias</surname><given-names>NE</given-names></name></person-group><article-title>Diagnosis and management of hyponatremia: a review</article-title><source>JAMA</source><year>2022</year><volume>328</volume><issue>3</issue><fpage>280</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1001/jama.2022.11176</pub-id><pub-id pub-id-type="pmid">35852524</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayus</surname><given-names>JC</given-names></name><name name-style="western"><surname>Negri</surname><given-names>AL</given-names></name><name name-style="western"><surname>Moritz</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KM</given-names></name><name name-style="western"><surname>Caputo</surname><given-names>D</given-names></name><name name-style="western"><surname>Borda</surname><given-names>ME</given-names></name><name name-style="western"><surname>Go</surname><given-names>AS</given-names></name><name name-style="western"><surname>Eghi</surname><given-names>C</given-names></name></person-group><article-title>Hyponatremia, inflammation at admission, and mortality in hospitalized COVID-19 patients: a prospective cohort study</article-title><source>Front Med (Lausanne)</source><year>2021</year><volume>8</volume><fpage>748364</fpage><pub-id pub-id-type="doi">10.3389/fmed.2021.748364</pub-id><pub-id pub-id-type="pmid">34926496</pub-id><pub-id pub-id-type="pmcid">PMC8674434</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barker</surname><given-names>T</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>VE</given-names></name><name name-style="western"><surname>Henriksen</surname><given-names>VT</given-names></name><name name-style="western"><surname>Brown</surname><given-names>KB</given-names></name><name name-style="western"><surname>Trawick</surname><given-names>RH</given-names></name><name name-style="western"><surname>Momberger</surname><given-names>NG</given-names></name><name name-style="western"><surname>Lynn</surname><given-names>RG</given-names></name></person-group><article-title>Is there a link between the neutrophil-to-lymphocyte ratio and venous thromboembolic events after knee arthroplasty? A pilot study</article-title><source>J Orthop Traumatol</source><year>2016</year><volume>17</volume><issue>2</issue><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1007/s10195-015-0378-3</pub-id><pub-id pub-id-type="pmid">26387114</pub-id><pub-id pub-id-type="pmcid">PMC4882298</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yao</surname><given-names>C</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Q</given-names></name></person-group><article-title>Predictive value of lymphocyte to monocyte ratio and monocyte to high-density lipoprotein ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study</article-title><source>J Orthop Surg Res</source><year>2018</year><volume>13</volume><issue>1</issue><fpage>211</fpage><pub-id pub-id-type="doi">10.1186/s13018-018-0910-2</pub-id><pub-id pub-id-type="pmid">30143011</pub-id><pub-id pub-id-type="pmcid">PMC6109316</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Shi</surname><given-names>D</given-names></name></person-group><article-title>Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study</article-title><source>J Orthop Surg Res</source><year>2018</year><volume>13</volume><issue>1</issue><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/s13018-018-0745-x</pub-id><pub-id pub-id-type="pmid">29482566</pub-id><pub-id pub-id-type="pmcid">PMC5828483</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosello</surname><given-names>A</given-names></name><name name-style="western"><surname>Pouwels</surname><given-names>KB</given-names></name><name name-style="western"><surname>De Cell&#232;s</surname><given-names>MD</given-names></name><name name-style="western"><surname>Van Kleef</surname><given-names>E</given-names></name><name name-style="western"><surname>Hayward</surname><given-names>AC</given-names></name><name name-style="western"><surname>Hopkins</surname><given-names>S</given-names></name><name name-style="western"><surname>Robotham</surname><given-names>JV</given-names></name><name name-style="western"><surname>Smieszek</surname><given-names>T</given-names></name><name name-style="western"><surname>Opatowski</surname><given-names>L</given-names></name><name name-style="western"><surname>Deeny</surname><given-names>SR</given-names></name></person-group><article-title>Seasonality of urinary tract infections in the United Kingdom in different age groups: longitudinal analysis of The Health Improvement Network (THIN)</article-title><source>Epidemiol Infect</source><year>2018</year><volume>146</volume><issue>1</issue><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1017/S095026881700259X</pub-id><pub-id pub-id-type="pmid">29168442</pub-id><pub-id pub-id-type="pmcid">PMC9134528</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afshar-Kharghan</surname><given-names>V</given-names></name><name name-style="western"><surname>Thiagarajan</surname><given-names>P</given-names></name></person-group><article-title>Leukocyte adhesion and thrombosis</article-title><source>Curr Opin Hematol</source><year>2006</year><volume>13</volume><issue>1</issue><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1097/01.moh.0000190107.54790.de</pub-id><pub-id pub-id-type="pmid">16319685</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>The Hoffa-like fracture of the tibial plateau: a clinical study</article-title><source>Int Orthop</source><year>2022</year><volume>46</volume><issue>6</issue><fpage>1387</fpage><lpage>1393</lpage><pub-id pub-id-type="doi">10.1007/s00264-022-05345-w</pub-id><pub-id pub-id-type="pmid">35182175</pub-id></element-citation></ref><ref id="CR43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitchen</surname><given-names>DS</given-names></name><name name-style="western"><surname>Richards</surname><given-names>J</given-names></name><name name-style="western"><surname>Smitham</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>LB</given-names></name></person-group><article-title>Does time to theatre affect the ability to achieve fracture reduction in tibial plateau fractures?</article-title><source>J Clin Med</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>138</fpage><pub-id pub-id-type="doi">10.3390/jcm11010138</pub-id><pub-id pub-id-type="pmid">35011877</pub-id><pub-id pub-id-type="pmcid">PMC8745337</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evangelopoulos</surname><given-names>D</given-names></name><name name-style="western"><surname>Chalikias</surname><given-names>S</given-names></name><name name-style="western"><surname>Michalos</surname><given-names>M</given-names></name><name name-style="western"><surname>Vasilakos</surname><given-names>D</given-names></name><name name-style="western"><surname>Pappa</surname><given-names>E</given-names></name><name name-style="western"><surname>Zisis</surname><given-names>K</given-names></name><name name-style="western"><surname>Koundis</surname><given-names>G</given-names></name><name name-style="western"><surname>Kokoroghiannis</surname><given-names>C</given-names></name></person-group><article-title>Medium-term results after surgical treatment of high-energy tibial plateau fractures</article-title><source>J Knee Surg</source><year>2020</year><volume>33</volume><issue>4</issue><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1055/s-0039-1677822</pub-id><pub-id pub-id-type="pmid">30727013</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>